Pazoo, Inc. (OTCBB:PZOO) entered into a binding letter of intent to acquire 40% stake in M.A. + Associates, LLC on March 25, 2014. Pazoo, Inc. (OTCBB:PZOO) entered into a membership interest purchase agreement to acquire 40% stake in M.A. + Associates, LLC on April 8, 2014. As part of consideration, Pazoo will pay $2 million in cash and issue 0.15 million shares of its Series C Preferred Stock. Out of which, $0.05 million will be paid upon the full execution of letter of intent, $0.05 million within fourteen days of the execution of the final agreements. $0.25 million will be placed in escrow, on the later of April 30, 2014 or the State of Nevada makes available the application to become a licensed medical marijuana testing laboratory. The remaining $1.65 million shall be paid upon final state approval of M.A. as a testing laboratory and licenses being issued therefore, in accordance with the payment schedule to be set forth in the final agreements. Pazoo shall be granted one seat on the Board of Directors and/or Board of Advisors of MA.

The deal is subject to execution of a mutually acceptable final agreement, receipt of all applicable consents, approvals, and authorizations including Board, partnership, third party, execution of employment agreements for Directors and Officers, regulatory approvals and substantial due diligence investigation. As on April 10, 2014, Pazoo, Inc. paid second installment of $0.05 million under the interest purchase agreement. As of May 23, 2014 Pazoo, Inc. paid another installment of $0.07 million. As of June 30, 2014, an additional total of $0.01 million has been paid to MA and Associates LLC in accordance with the agreement.

Integrated Capital Partners, Inc acted as advisor for Pazoo. Integrated Capital Partners will be paid a consulting fee with regard to transaction in 5 million shares of the Pazoo's Series C Preferred Stock.